UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001501
Receipt number R000001488
Scientific Title A phase I/II study of percutaneous radiofrequency ablation for osteoid osteoma (JIVROSG-0704)
Date of disclosure of the study information 2008/11/12
Last modified on 2011/05/14 15:10:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase I/II study of percutaneous radiofrequency ablation for osteoid osteoma (JIVROSG-0704)

Acronym

Percutaneous radiofrequency ablation for osteoid osteoma (JIVROSG-0704)

Scientific Title

A phase I/II study of percutaneous radiofrequency ablation for osteoid osteoma (JIVROSG-0704)

Scientific Title:Acronym

Percutaneous radiofrequency ablation for osteoid osteoma (JIVROSG-0704)

Region

Japan


Condition

Condition

osteoid osteoma

Classification by specialty

Orthopedics Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of percutaneous radiofrequency ablation for osteoid osteoma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Following the percutaneous insertion of a radiofrequency needle, radiofrequency ablation of nidus of osteoid osteoma is to be performed.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Clinically or radiographically diagnosed osteoid osteoma.
2) Target lesion (i.e. nidus) is visualized with CT.
3) Not a candidate for surgery or refuse surgery.
4) Oral analgesic use for pain control of osteioid osteoma.
5) Adequate cardiac, hepatic, renal, respiratory, coagulation, and bone marrow functions.
6) Performans status of 0-2.
7) Written informed consent from the patient or the delegate.

Key exclusion criteria

1) Cardiac pacemaker.
2) Vital artery or nerve on the needle route.
3) Vital neural structures in the field of ablation.
4) Maximum diameter of the target lesion (i.e. nidus) > 1.5cm.
5) Pretreatment Visual Analogue Scale < 2.
6) Previous locoregional treatment for the target lesion.
7) Not applicable for anesthesia (general, spinal, or epidural).
8) Pregnant.
9) Not eligible determined by the responding physician.

Target sample size

21


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keigo Endo

Organization

Gunma University

Division name

Department of Radiology and Radiation Oncology

Zip code


Address

3-39-15, Showa-cho, Maebashi 3718511, JAPAN

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Yasuaki Arai

Organization

JIVROSG, Coordinating Office

Division name

Division of Diagnostic Radiology, National Cancer Center Hospital

Zip code


Address

5-1-1, Tsukiji, Chu0-ku, Tokyo, 104-0045, Japan

TEL

03-3542-2511

Homepage URL

http://jivrosg.umin.jp/

Email

jivrosgoffice@ml.res.ncc.go.jp


Sponsor or person

Institute

Japan Interventional Radiology in Oncology Study Group (JIVROSG)

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 11 Month 12 Day


Related information

URL releasing protocol

https://center.umin.ac.jp/islet/jivrosg/

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 02 Month 29 Day

Date of IRB


Anticipated trial start date

2008 Year 04 Month 01 Day

Last follow-up date

2010 Year 05 Month 01 Day

Date of closure to data entry

2010 Year 10 Month 01 Day

Date trial data considered complete

2010 Year 11 Month 01 Day

Date analysis concluded

2010 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 11 Month 12 Day

Last modified on

2011 Year 05 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001488


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name